In March 2009, RAND conducted a survey of a nationally representative sample of adults age 18 and over (n=5,203) to collect data on the receipt of the influenza vaccine in the United States during the 2008–2009 vaccination season. This overview of the survey results will provide public health officials and other stakeholders information on vaccination rates for all adults and for adults with one or more of the following indications: being age 50–64 or age 65 or older, being 18–49 and having a high-risk health condition, being a health care worker, or having close personal contact with high-risk individuals.
This survey was conducted with the funding and support of GlaxoSmithKline (GSK) performed under the auspices of RAND Health.
This report is part of the RAND Corporation Occasional paper series. RAND occasional papers may include an informed perspective on a timely policy issue, a discussion of new research methodologies, essays, a paper presented at a conference, or a summary of work in progress. All RAND occasional papers undergo rigorous peer review to help ensure that they meet high standards for research quality and objectivity.
Permission is given to duplicate this electronic document for personal use only, as long as it is unaltered and complete. Copies may not be duplicated for commercial purposes. Unauthorized posting of RAND PDFs to a non-RAND Web site is prohibited. RAND PDFs are protected under copyright law. For information on reprint and linking permissions, please visit the RAND Permissions page.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.